Indian Court Rejects Whistle-Blower's Suit For Regulatory Fixes
This article was originally published in Scrip
Executive Summary
India's apex court has declined to admit Ranbaxy whistle-blower Dinesh Thakur's petitions that sought "urgent intervention" to improve India's drug regulatory standards and challenged the constitutionality of certain rules under the Drugs and Cosmetics Rules 1945.